Efficacy and Safety of the ACAT Inhibitor CS-505 (Pactimibe) for Reducing the Progression of Coronary Artery Disease
Clinical trial NCT00185042 · COMPLETED
Trial details
- NCT number
- NCT00185042
- Sponsor
- Daiichi Sankyo
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-11-01
- Enrollment
- 534
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.